Filters
Phase
Intervention Type
Status
Location:
LocationClose
Distance
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Need to find the closest trial?
Sort By Distance
Save trials for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
2 clinical trials found
A Phase 4, Open-Label Study to Evaluate the Efficacy of Valbenazine on Clinician- and Patient-Reported Outcomes in Patients With Tardive Dyskinesia (TD) Who Remain Symptomatic While on Deutetrabenazine or After Discontinuing Prior TD Treatment With a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
Enrollment Status: Recruiting
Publish Date: September 23, 2025
Intervention Type: Drug
Study Phase: Phase 4
Summary: This study will evaluate the efficacy of valbenazine on clinician- and patient-reported outcomes in participants with TD while receiving or after stopping a VMAT2 inhibitor.
Impact of Deutetrabenazine on Functional Speech and Gait Dynamics in Huntington Disease
Who is this study for: Patients with Huntington Disease
Enrollment Status: Recruiting
Publish Date: February 13, 2025
Intervention Type: Drug
Study Drug: Deutetrabenazine
Study Phase: Phase 2/Phase 3
Summary: Examine the effects of deutetrabenazine on functional speech and gait impairment
Showing 1-2 of 2
Last Updated: 10/31/2025